|
YKT6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.598420E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.955130E-04 |
| Normal-vs-Stage2 |
4.365900E-02 |
| Normal-vs-Stage3 |
1.704160E-01 |
| Normal-vs-Stage4 |
2.105400E-01 |
| Stage1-vs-Stage2 |
9.681600E-01 |
| Stage1-vs-Stage3 |
3.202200E-01 |
| Stage1-vs-Stage4 |
1.655750E-03 |
| Stage2-vs-Stage3 |
4.990000E-01 |
| Stage2-vs-Stage4 |
1.251630E-02 |
| Stage3-vs-Stage4 |
3.903600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.018280E-02 |
| Normal-vs-AfricanAmerican |
5.484200E-01 |
| Normal-vs-Asian |
7.608800E-01 |
| Caucasian-vs-AfricanAmerican |
3.771600E-01 |
| Caucasian-vs-Asian |
3.247600E-01 |
| AfricanAmerican-vs-Asian |
6.587400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.940310E-02 |
| Normal-vs-Female |
7.683900E-02 |
| Male-vs-Female |
5.655400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.987200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.785820E-02 |
| Normal-vs-Age(61-80Yrs) |
6.710100E-02 |
| Normal-vs-Age(81-100Yrs) |
4.879600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.624400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.553200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.146600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.247000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.872200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.872600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.705030E-01 |
| Normal-vs-Grade 2 |
2.6444000000847E-07 |
| Normal-vs-Grade 3 |
1.145960E-01 |
| Normal-vs-Grade 4 |
1.538340E-02 |
| Grade 1-vs-Grade 2 |
8.465000E-01 |
| Grade 1-vs-Grade 3 |
5.053200E-01 |
| Grade 1-vs-Grade 4 |
4.218400E-02 |
| Grade 2-vs-Grade 3 |
7.555400E-03 |
| Grade 2-vs-Grade 4 |
1.20630000000066E-06 |
| Grade 3-vs-Grade 4 |
4.204100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.74259995111959E-09 |
| Normal-vs-ccB subtype |
9.857600E-01 |
| ccA subtype-vs-ccB subtype |
2.55100000001729E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.127190E-01 |
| Normal-vs-N1 |
9.334500E-02 |
| N0-vs-N1 |
1.792130E-02 |
|
|
